Dr. Kadia was president and CEO of EAG Laboratories, a global scientific services company, and president of the life sciences division at Life Technologies, a biotech company that was acquired by Thermo Fisher Scientific in 2014.
In his new role on NuVasive’s board, Dr. Kadia will help drive innovation and support the company’s goal of transforming surgery. In January, a study published in The Spine Journal validated its single-position spine surgery with the X360 procedural approach as improving efficiency while reducing complications and hospital length of stay.
More articles on spine surgery:
Drs. John Spitalieri, Kern Singh and more: 6 spine surgeons in the news
M6-C vs. ACDF: The Spine Journal publishes 2-year study data
What 4 spine surgeons expect from payer negotiations in 2021
